Athenex (ATNX) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 96 252 sessions, May 24, 2022 to May 24, 2023
- Largest daily move
- -60.7% close of May 15, 2023
- 1-year change
- -98% closing prices, May 24, 2022 to May 24, 2023
- 5-year change
- -99.9% closing prices, May 24, 2018 to May 24, 2023
Company Description
Athenex (Nasdaq: ATNX) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.3M.
ATNX has declined 98.0% over the past year. The last closing price was $0.2031.
This page collects what Stock Titan holds for ATNX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Athenex (ATNX) closed at $0.2031 on May 24, 2023. Over the past 12 months, the price has lost 98.0%.
ATNX Metrics & Rankings
Price returns through May 24, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Athenex has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, stock split, conferences. View all ATNX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATNX Company Profile & Sector Positioning
Athenex (ATNX) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing ATNX often look at related companies in the same sector, including Mallinckrodt Plc (MNKKQ), Refined Metals Corp (CADMF), CHINA INFRASTRUCTURE CONSTRUCTI (CHNC), Vencanna Ventures (TPPRF), and Nuvo Pharmaceuticals Inc (MRVFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATNX's relative position within its industry.